期刊文献+

CRP与PTX3在动脉粥样硬化发病过程中的作用比较

The Comparison of CRP and PTX3 in the Pathogenesis of Atherosclerosis
下载PDF
导出
摘要 目的越来越多的研究证实炎症与动脉粥样硬化的形成相关,为了寻找足够敏感性和特异性的炎症指标,既可阐明致病机制,又可用于临床实践,现对PTX3与CRP的相关特性进行系统回顾。方法通过回顾动脉粥样炎症过程、CRP在动脉粥样过程中的作用、PTX3在动脉粥样过程中的作用以及CRP与PTX3作为动脉粥样硬化生物标志物在临床上的应用。结果通过对比,可推论作为结构相似的炎症急相期蛋白,分子结构更大的PTX3更早的参与到了动脉粥样的炎症过程,可能起到保护作用。结论 PTX3间接刺激了CRP的产生,而CRP的产生亦进一步刺激PTX3的产生。 Objective To study the formation of more and more associated inflammation and atherosclerosis, in order to find enough sensitivity and specificity of the markers of inflammation, which can explain the pathogenic mechanism, but also can be used in clinical practice, the correlation properties of PTX3 and CRP systematic review. Methods Through the review of atherosclerotic inflammation in atherosclerotic process, CRP process, PTX3 in the atherosclerotic process and application of CRP and PTX3 as biomarkers of atherosclerosis in clinic. Results By comparison, can be inferred as a structure similar to acute phase inflammatory protein, the molecular structure of PTX3 seems to be more involved in the inflammatory process of early atherosclerosis, may play a protective role. Conclusion PTX3 indirectly stimulate the production of CRP, and CRP have also further stimulate the production of PTX3.
作者 金晶 曾惠
机构地区 吉林省人民医院
出处 《中国继续医学教育》 2015年第14期25-26,共2页 China Continuing Medical Education
关键词 CRP PTX3 动脉粥样硬化 CRP PTX3 Atherosclerosis
  • 相关文献

参考文献3

  • 1ROSS R. Atherosclerosis-an inflammatory disease[J]. N EnglJ Med., 1999, 340 (2) : 115-126.
  • 2范乐明.动脉粥样硬化炎症机制的再认识[J].中国动脉硬化杂志,2005,13(3):249-253. 被引量:73
  • 3WooP, korenbergJR, Whitehead AS, et al. Charactefizamn offenomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component[J]. J Biol Chem., 1985, 260 ( 24 ) : 13384-13388.

二级参考文献61

  • 1Roes R. Atherosclemsis - an inflammatory disease. N Engl J Med, 1999,340:115-126.
  • 2Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages contributions to atherosclerosis.Arterioscler Thromb Vasc Biol, 2004, 24(1): 23-28.
  • 3Rama Natarajan, Nadler JL.Lipid Inflammatory Mediators in Diabetic Vascular Disease.Arterioscler Thromb Vasc Biol,2004,24:1542-548.
  • 4Hosono M, de Boer OJ, van der Wal AC, van der Loos CM, Teeling P, Piek JJ,et al.Increased expression of T cell activation markers (CD25,CD26,CD40Land CD69)in atherectomy specimens of patients with unstable angina and acute myocardial infarction.Atherosclerosis,2003,168:73-80.
  • 5Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med, 2002, 347(1): 5-12.
  • 6Libby P. Inflammation in atherosclemsis. Nature,2002,420:868-874.
  • 7Miller YI,Chang MK, Binder CJ, Shaw PX, Witztum JL. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol, 2003, 14: 437-445.
  • 8Maggi E, Perani G, Falaschi F, Frattoni A, Martignoni A, Finardi G, et al.Autoantibodies against oxidized low density lipoproteins in patients with coronary disease. Presse Med, 1994, 23: 1158-162.
  • 9Mehta JL, Saldeen TG, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosos and coronary artery disease. J Am Coll Cardiol, 1998, 31:1217-225.
  • 10Hofman A. Lipopotein-associated phospholipase A2 is associated with risk of coronary heart disesse and stroke. The Rotterdam study. Presented at the European Society of Cardiology Congress 2004. Munich, Germarry, 30 August 2004.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部